Fundz

CorMedix Inc. Announces Appointment of Chief Legal Officer

PUBLIC · CRMDDec 15, 2023

Position

Chief Legal Officer

Company

CorMedix

Beth Zelnick Kaufman
bzelnick-kaufman@cormedix.com
Berkeley HeightsBiotechnologyHealth CareTherapeutics

Description

CorMedix Inc. , a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced the appointment of Beth Zelnick Kaufman, Esq. as EVP, Chief Legal Officer, and Corporate Secretary, effective December 12, 2023

Quick answer

CorMedix Inc. Announces Appointment of Chief Legal Officer (December 15, 2023). CorMedix is based in Berkeley Heights, New Jersey, United States.

What did CorMedix announce on December 15, 2023?
CorMedix Inc. , a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced the appointment of Beth Zelnick Kaufman, Esq. as EVP, Chief Legal Officer, and Corporate Secretary, effective December 12, 2023
What does CorMedix do?
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases.
Where is CorMedix based?
CorMedix is based in Berkeley Heights, New Jersey, United States.
Which similar companies made leadership changes around the same time?
CTRL Therapeutics (December 12, 2023), Intensity Therapeutics (December 12, 2023), Bicara Therapeutics (December 18, 2023) and Neumora (December 12, 2023) also announced leadership changes within 45 days of CorMedix.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at CorMedix, and when

A new leader at CorMedix brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day CorMedix raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CorMedix, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CorMedix. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CorMedix

Location

Berkeley Heights, New Jersey, United States

About

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on developing its lead product DefenCath®, a novel, non-antibiotic antimicrobial solution designed to prevent costly and life-threatening bloodstream infections associated with the use of central venous catheters in patients undergoing chronic hemodialysis. DefenCath has been designated by FDA as Fast Track and as a Qualified Infectious Disease Product (QIDP), and the original New Drug Application (NDA) received priority review in recognition of its potential to address an unmet medical need. DefenCath was approved by the FDA on November 15, 2023 and the Company has indicated an estimated initial launch in 1Q 2024. CorMedix also intends to develop DefenCath as a catheter lock solution for use in other patient populations, and the Company is working with top-tier researchers to develop taurolidine-based therapies for rare pediatric cancers. For more information visit: www.cormedix.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CorMedix changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Beth
Likely contact at this company
••••••••@••••••••

See Beth's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for CorMedix's next move

Learn about Strategic plan

CorMedix changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.